These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8315960)
41. [HIV seroprevalence in patients with tuberculosis]. Nagai H; Kawabe Y; Nagayama N; Tanaka Y; Nishiyama M; Suzuki M; Masuda K; Baba M; Hori A; Tamura A; Akagawa S; Machida K; Kurashima A; Yotsumoto H; Mori M; Kimura S Kekkaku; 2001 Nov; 76(11):679-84. PubMed ID: 11766358 [TBL] [Abstract][Full Text] [Related]
42. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Tembo G; Machiels L; Bem C; Steenbergen G; Pobee JO; Nunn PP J Trop Med Hyg; 1993 Feb; 96(1):1-11. PubMed ID: 8429569 [TBL] [Abstract][Full Text] [Related]
43. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis. Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968 [TBL] [Abstract][Full Text] [Related]
44. [Respiratory function in heroin addicts with or without HIV infection. Study of 107 cases with a 6-month follow-up of 36 subjects]. Escamilla R; Pecoul J; Hermant C; Besombes JP; Krempf M Rev Mal Respir; 1992; 9(4):425-9. PubMed ID: 1509186 [TBL] [Abstract][Full Text] [Related]
45. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980 [TBL] [Abstract][Full Text] [Related]
46. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250 [TBL] [Abstract][Full Text] [Related]
47. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group]. Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232 [TBL] [Abstract][Full Text] [Related]
48. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain. Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho Martinez F J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):221-6. PubMed ID: 9883433 [TBL] [Abstract][Full Text] [Related]
49. Two-step tuberculin skin testing of injection drug users recruited from community-based settings. Lifson AR; Grant SM; Lorvick J; Pinto FD; He H; Thompson S; Keudell EG; Stark MJ; Booth RE; Watters JK Int J Tuberc Lung Dis; 1997 Apr; 1(2):128-34. PubMed ID: 9441076 [TBL] [Abstract][Full Text] [Related]
50. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study. Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423 [TBL] [Abstract][Full Text] [Related]
51. [Prevalence of infection by the human immunodeficiency virus type 1 in drug addicts in Madrid, over a 5 year period]. Sopelana P; Diéguez A; Bautista L Med Clin (Barc); 1991 Nov; 97(16):601-3. PubMed ID: 1766279 [TBL] [Abstract][Full Text] [Related]
52. HIV infection in newly diagnosed tuberculosis patients in Ndola, Zambia. Simooya OO; Maboshe MN; Kaoma RB; Chimfwembe EC; Thurairajah A; Mukunyandela M Cent Afr J Med; 1991 Jan; 37(1):4-7. PubMed ID: 2060007 [TBL] [Abstract][Full Text] [Related]
53. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Daley CL; Hahn JA; Moss AR; Hopewell PC; Schecter GF Am J Respir Crit Care Med; 1998 Jan; 157(1):19-22. PubMed ID: 9445273 [TBL] [Abstract][Full Text] [Related]
54. Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission. Piazza M; Chirianni A; Picciotto L; Tullio Cataldo P; D'Abbraccio M; Borgia G; Orlando R; Valletta G; Matarasso S; Vaia E Boll Soc Ital Biol Sper; 1991 Dec; 67(12):1047-52. PubMed ID: 1840796 [TBL] [Abstract][Full Text] [Related]
55. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts. Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660 [TBL] [Abstract][Full Text] [Related]
56. [Rapid spread of HIV infections among narcotic addicts]. Stapiński A; Mazurkiewicz W; Ochelska B; Głuska T Przegl Dermatol; 1990; 77(3):197-200. PubMed ID: 2244014 [TBL] [Abstract][Full Text] [Related]
57. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Richter C; Koelemay MJ; Swai AB; Perenboom R; Mwakyusa DH; Oosting J Tuber Lung Dis; 1995 Dec; 76(6):510-7. PubMed ID: 8593371 [TBL] [Abstract][Full Text] [Related]
58. [Pulmonary tuberculosis: differences between patients seropositive and seronegative for the acquired immunodeficiency virus]. Fernández Revuelta A; Arazo Garcés P; Aguirre Errasti JM; Arribas Llorente JL An Med Interna; 1993 Aug; 10(8):381-5. PubMed ID: 8218782 [TBL] [Abstract][Full Text] [Related]
59. [Study of tuberculosis in Huelva prison]. Sánchez Moreno A; Villena Martínez L; Castro Recio JM; Aguayo Canela M; Pujol de la Llave E An Med Interna; 1997 Dec; 14(12):607-10. PubMed ID: 9518028 [TBL] [Abstract][Full Text] [Related]
60. [Thrombocytopenia associated with human immunodeficiency virus infection. Immunologic study of 60 patients addicted to parenteral drugs]. Muñiz-Díaz E; Domingo P; López M; Pujol-Moix N; Fuster M; Madoz P Med Clin (Barc); 1993 Dec; 101(20):761-5. PubMed ID: 8114535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]